A Cancer-Related Fatigue Clinic: Opportunities and Challenges

Authors:
Carmen P. Escalante From the Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

Search for other papers by Carmen P. Escalante in
Current site
Google Scholar
PubMed
Close
 MD
,
Ellen Manzullo From the Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

Search for other papers by Ellen Manzullo in
Current site
Google Scholar
PubMed
Close
 MD
, and
Rosalie Valdres From the Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

Search for other papers by Rosalie Valdres in
Current site
Google Scholar
PubMed
Close
 RN, MSN, FNP, CNS
Full access

Cancer-related fatigue (CRF) is the most prevalent symptom of cancer, occurring in 60% to 90% of patients and surpassing pain in frequency. CRF may increase patients' anxieties and hamper their quality of life. We developed a CRF clinic in 1998 because we believed there needed to be a more focused effort on the education, evaluation, and treatment of CRF for our patients. Since then, we have gained clinical insights into the planning, development, and evolution of this endeavor. Our objective is to share our experiences and provide preliminary analysis of the first 123 patients evaluated in this clinic.

Correspondence: Carmen P. Escalante, MD, The University of Texas M.D. Anderson Cancer Center, Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, 1515 Holcombe, Box 437, Houston, TX 77030. E-mail: cescalan@mdanderson.org
  • Collapse
  • Expand
  • 1

    Mock V, Atkinson A & Barsevick A et al. NCCN cancer-related fatigue clinical practice guidelines in oncology. Oncology 2000;14:151161.

  • 2

    Cella D, Davis K & Breitbart W et al. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001;19:33853391.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Cella D, Peterman A & Passik S et al. Progress toward guidelines for the management of fatigue. Oncology 1998;12:369377.

  • 4

    Demetri GD, Kris M & Wade J et al. Quality of life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. J Clin Oncol 1998;16:34123425.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Glaus A, Crow R, Hammond S. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer 1996;4:8296.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Mock V, Dow KH & Meores C et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997;24:9911000.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Bloom JR, Fobair P & Grintz E et al. Psychosocial outcomes of cancer: a comparative analysis of Hodgkin's disease and testicular cancer. J Clin Oncol 1998;1:979988.

  • 8

    Broeckel JA, Jacobsen P & Horton J et al. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 1998;16:16891696.

  • 9

    Mendoza TR, Wang XS & Cleeland CS et al. The rapid assessment of fatigue in cancer patients. Cancer 1999;85:11861196.

  • 10

    Cleeland CS, Ryan KM. Pain assessment: Global use of the brief pain inventory. Ann Acad Med Singapore 1994;23:129138.

  • 11

    Steer RA, Beck AT & Brown G et al. Self-reported depressive symptoms that differentiate recurrent-episode major depression from dysthymic disorders. J Clin Psychol 1987;43:246250.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Cleeland CS, Mendoza TR & Wang SX et al. Assessing symptom distress in cancer patients. The M D Anderson Symptom Inventory. Cancer 2000;89:16341646.

  • 13

    Harvey RF, Jellinek HM. Functional performance assessment: a program approach. Arch Phys Med Rehabil 1981;62:456460.

  • 14

    Harvey RF, Jellinek HM. Patient profiles: utilization in functional performance assessment. Arch Phys Med Rehabil 1983;64:268271.

  • 15

    Stewart AL, Hays RD, Ware JF Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988;26:724735.

  • 16

    Beck AT, Epstein N & Brown G et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893897.

  • 17

    Zubrod CG, Schneiderman M & Frei E et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and trimethylene thiophosphoramide. J Chronic Dis 1960;11:7.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Escalante CP, Grover T & Johnson BA et al. A fatigue clinic in a comprehensive cancer center: design and experiences. Cancer 2001;92(Suppl 6):17081713.

  • 19

    Berger AM, W SN. An explanatory model of fatigue in women receiving adjuvant breast cancer chemotherapy. Nurs Res 2001;50:4252.

  • 20

    Jacobsen PB, Hann DM & Azarello LM et al. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course and correlates. J Pain Symptom Manage 1999;18:233242.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21

    Dodd MJ, Miaskowski C, Paul SM. Symptom cluster and their effects on the functional status of patients with cancer. Oncol Nurs Forum 2001;28:465470.

  • 22

    Cleeland CS, Demetri GD & JG et al. Identifying hemoglobin level for optional quality of life: Results of an incremental analysis (Abstr). Proc Am Soc Clin Oncol 1999;18:574A, 2215.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Glaspy J, Bukowski R & Steinberg D et al. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 1997;15:12181234.

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 902 628 150
PDF Downloads 104 63 5
EPUB Downloads 0 0 0